Therefore, additional statistical analyses on a potential correlation between C4.4A and galectin-3 expression and clinical parameters of grading, staging and disease-free survival were performed only for colorectal cancer and liver metastases derived thereof. The gene discussed is LGALS3; the disease is colorectal cancer.